# KI data from Sander et al. Allosteric feedback inhibition enables robust amino acid biosynthesis
# in E. coli by enforcing enzyme overabundance. Cell. 2019.
# No annotated inhibition for L-ALPHA-ALANINE, L-ASPARTATE, GLT, GLN, GLY
# Other sources are noted in _notes and often come from EcoCyc
# Reverse and degradation enzymes are considered to be the same for calculation purposes but could be separated in the future with additional data
"Amino acid"	"Enzymes"	"Reverse enzymes"	"kcat (1/units.s)"	"KI, lower bound (units.mmol/units.L)"	"KI, upper bound (units.mmol/units.L)"	"Reverse amino acids"	"KM, reverse (units.mmol/units.L)"	"KM, degradation (units.mmol/units.L)"	"Upstream amino acids"	"KM, upstream (units.mmol/units.L)"	"Downstream amino acids"	"_notes"
"ARG"	["N-ACETYLTRANSFER-CPLX"]	["ARGSUCCTRAN-MONOMER"]	654	0.15	0.15	{"GLT": 2}	NaN	NaN	{"GLT": 2}	{"GLT": 2.65}	{}	(ArgA), (AstA), upstream KM: Takahara 2007, TODO: AdiA and SpeA can also degrade
"ASN"	["ASNSYNA-CPLX", "ASNSYNB-CPLX"]	["EG12407-MONOMER", "ANSA-CPLX"]	NaN	0.12	0.12	{"L-ASPARTATE": 1}	4	NaN	{"L-ASPARTATE": 1}	{}	{}	(AsnA, AsnB), (IaaA, AnsA), reverse KM: Hejazi 2002 (for IaaA), AnsB can also degrade in the periplasm
"CYS"	["CYSSYNMULTI-CPLX", "CPLX0-237"]	["G7622-MONOMER", "TRYPTOPHAN-CPLX", "ACSERLYB-CPLX"]	772	0.001	0.001	{}	NaN	NaN	{"SER": 1}	{"SER": 1.17}	{"MET": 1}	(CysE), (CyuA, TnaA, CysM), upstream KM: Hindson 2003, TODO: AspC can also degrade to Glt
"HIS"	["CPLX0-7614"]	["TYRB-DIMER"]	NaN	0.012	0.1	{}	NaN	2.57	{"GLN": 1}	{"GLN": 0.24}	{}	(HisG), (TyrB), upstream KM: Klem 1993 (for HisHF reaction step), degradation KM: Dolzan 2004 https://doi.org/10.1016/j.febslet.2004.06.075, TODO: add degradation reaction in metabolism, TODO: degradation not reverse enzyme
"ILE"	["THREDEHYDSYN-CPLX"]	["BRANCHED-CHAINAMINOTRANSFER-CPLX"]	NaN	0.06	0.06	{"GLT": 1}	0.52	NaN	{"GLT": 1}	{}	{}	(IlvA), (IlvE), reverse KM: LeePeng 1979 (for IlvE), upstream KM: Eisenstein 1991
"LEU"	["2-ISOPROPYLMALATESYN-MONOMER"]	["BRANCHED-CHAINAMINOTRANSFER-CPLX"]	NaN	0.28	0.28	{"GLT": 1}	0.58	NaN	{"GLT": 1}	{}	{}	(LeuA), (IlvE), reverse KM: LeePeng 1979 (for IlvE)
"LYS"	["DIHYDRODIPICSYN-CPLX"]	["LYSDECARBOX-CPLX", "LDC2-CPLX"]	104	0.21	3.9	{"GLT": 1}	NaN	NaN	{"GLT": 1}	{"GLT": 1.21}	{}	(DapA), (CadA, LdcC), ASP upstream KM: Keng 1996 (for LysC), GLT upstream KM: Cox 1996 (for ArgD)
"MET"	["HOMSUCTRAN-CPLX"]	["S-ADENMETSYN-CPLX"]	22	0.1	4	{}	NaN	0.11	{"L-ASPARTATE": 1, "CYS": 1}	{"L-ASPARTATE": 0.97, "CYS": 0.05}	{}	(MetA), (MetK), ASP upstream KM: Chassagnole 2001 (for ThrA), CYS upstream KM: Holbrook 1990 (for MetB), degradation KM: Taylor 2003 (for MetK), TODO: degradation not reverse enzyme
"PHE"	["CHORISMUTPREPHENDEHYDRAT-CPLX"]	["BRANCHED-CHAINAMINOTRANSFER-CPLX", "ASPAMINOTRANS-DIMER", "TYRB-DIMER"]	32	0.1	0.6	{"GLT": 1}	0.333	NaN	{"GLT": 1}	{}	{}	(PheA), (IlvE, AspC, TyrB), reverse KM: Mavrides 1975 (for TyrB)
"PRO"	["GLUTKIN-CPLX"]	["PUTA-CPLX", "PUTA-CPLXBND"]	53	0.02	0.15	{"GLT": 1}	2.7	NaN	{"GLT": 1}	{}	{}	(ProB), (PutA), upper limit from Perez-Arellano. 2010. https://doi.org/10.1016/j.jmb.2010.10.019, reverse KM: Abrahamson 1983 (for PutA)
"SER"	["PGLYCDEHYDROG-CPLX"]	["CPLX0-7622", "LSERINEDEAM1-MONOMER", "THREDEHYDCAT-CPLX", "LSERINEDEAM2-MONOMER"]	29	0.005	0.37	{}	NaN	NaN	{"GLT": 1}	{}	{"CYS": 1, "GLY": 1, "MET": 1, "TRP": 1}	(SerA), (TdcG, SdaA, TdcB, SdaB), TODO: degradation not reverse enzyme
"THR"	["ASPKINIHOMOSERDEHYDROGI-CPLX"]	["THREDEHYDCAT-CPLX", "EG12293-MONOMER", "THREODEHYD-CPLX", "LTAA-CPLX"]	NaN	0.097	0.167	{}	NaN	6.5	{"L-ASPARTATE": 1}	{"L-ASPARTATE": 0.97}	{}	(ThrA), (TdcB, YiaY Tdh, LtaE), upstream KM: Chassagnole 2001, degradation KM: Anjem 2012 (for Tdh), TODO: degradation not reverse enzyme
"TRP"	["ANTHRANSYN-CPLX"]	["TRYPTOPHAN-CPLX"]	NaN	0.17	0.17	{}	NaN	0.12	{"GLN": 1, "SER": 1}	{}	{}	(TrpDE), (TnaA), degradation KM: Kawata 1990 (for TnaA), TODO: degradation not reverse enzyme
"TYR"	["CHORISMUTPREPHENDEHYDROG-CPLX"]	["ASPAMINOTRANS-DIMER", "TYRB-DIMER"]	71	0.1	0.1	{"GLT": 1}	0.625	NaN	{"GLT": 1}	{}	{}	(TyrA), (AspC, TyrB), reverse KM: Mavrides 1975 (for TyrB)
"VAL"	["ACETOLACTSYNI-CPLX"]	["BRANCHED-CHAINAMINOTRANSFER-CPLX"]	38.5	0.078	0.1	{"GLT": 1}	3.13	NaN	{"GLT": 1}	{}	{}	(IlvB), (IlvE), reverse KM: LeePeng 1979 (for IlvE)
# Added from other sources
"L-ALPHA-ALANINE"	["CPLX0-7887", "CPLX0-7888", "VALINE-PYRUVATE-AMINOTRANSFER-MONOMER", "CPLX0-246", "CPLX0-248"]	["CPLX0-7887", "CPLX0-7888"]	NaN	NaN	NaN	{"GLT": 1}	4.9	NaN	{"GLT": 1}	{}	{}	(AlaC, AlaA, AvtA, SufS, IscS), (AlaC, AlaA), reverse KM: Kim 2010 (for AlaA), TODO: DadX, Alr, MetC and MalY can also degrade
"L-ASPARTATE"	["ASPAMINOTRANS-DIMER"]	["ASPAMINOTRANS-DIMER"]	670	NaN	NaN	{"GLT": 1}	NaN	NaN	{"GLT": 1}	{}	{"ASN": 1, "MET": 1, "THR": 1}	(AspC), (AspC)
"GLT"	["GLUTAMATESYN-CPLX", "GDHA-CPLX"]	["GLUTAMATESYN-CPLX", "GDHA-CPLX"]	NaN	NaN	NaN	{}	NaN	2.3	{}	{}	{"L-ALPHA-ALANINE": 1, "ARG": 2, "ASN": 1, "L-ASPARTATE": 1, "CYS": 1, "GLN": 1, "GLY": 1, "HIS": 1, "ILE": 1, "LEU": 1, "LYS": 1, "MET": 2, "PHE": 1, "PRO": 1, "SER": 1, "THR": 1, "TRP": 2, "TYR": 1, "VAL": 1}	(GltBD, GdhA), (GltBD, GdhA), degradation KM: Sharkey 2008, TODO: other degradation pathways exist
"GLN"	["GLUTAMINESYN-OLIGOMER"]	["ASNSYNB-CPLX", "CPLX0-7694", "CPLX0-7695", "GLUTAMATESYN-CPLX", "CARBPSYN-CPLX", "CTPSYN-CPLX", "GMP-SYN-CPLX", "GLUTAMIDOTRANS-CPLX"]	36	NaN	NaN	{"GLT": 1}	0.25	NaN	{"GLT": 1}	{"GLT": 3.3}	{"HIS": 1, "TRP": 1}	(GlnA), (AsnB, GlsA, GlsB, GltBD, CarBA, PyrG, GuaA, HisHF), reverse KM: Miller 1972 (for GltBD), upstream KM: Pearson 2005
"GLY"	["GLYOHMETRANS-CPLX"]	["GLYOHMETRANS-CPLX"]	11	NaN	NaN	{"SER": 1}	0.25	NaN	{"SER": 1}	{"SER": 0.14}	{}	(GlyA), (GlyA), reverse KM: Hopkins 1986, upstream KM: Florio 2009, TODO: degradation pathway exists
"L-SELENOCYSTEINE"	["CPLX0-246"]	["CPLX0-246"]	NaN	NaN	NaN	{}	NaN	NaN	{}	{}	{}	(SufS), (SufS), mainly just a placeholder for Selenocysteine because the model does not explicitly produce it
